CARISTO DIAGNOSTICS
Caristo Diagnostics is revolutionizing cardiovascular diagnostics and risk prediction with its advanced, AI-based CT imaging analysis tools.
CARISTO DIAGNOSTICS
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Medical Medical Device
Founded:
2018-06-22
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.caristo.com
Total Employee:
11+
Status:
Active
Contact:
+44 1865 950720
Email Addresses:
[email protected]
Total Funding:
5.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Google Maps JsDelivr
Similar Organizations
Cara Care
Cara Care is a digital gut health platform that offers an app-based treatment to help patients with chronic gastrointestinal problems.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
Xip
Xip produces disposable blood analyzers that wirelessly upload lab-quality clinical measurements in minutes.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Venture Round - Caristo Diagnostics
Longwall Venture Partners
Longwall Venture Partners investment in Venture Round - Caristo Diagnostics
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP investment in Venture Round - Caristo Diagnostics
BGF Ventures
BGF Ventures investment in Venture Round - Caristo Diagnostics
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Caristo Diagnostics
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - Caristo Diagnostics
Longwall Venture Partners
Longwall Venture Partners investment in Seed Round - Caristo Diagnostics
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP investment in Seed Round - Caristo Diagnostics
Official Site Inspections
http://www.caristo.com
- Host name: 41.64.214.35.bc.googleusercontent.com
- IP address: 35.214.64.41
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Caristo Diagnostics"
Caristo.com
Mar 19, 2024 Heart & Lung Health (HLH), a UK-wide network of over 110 expert cardiothoracic radiologists, has partnered with Caristo Diagnostics, a leading cardiac disease diagnostics …See details»
Caristo Diagnostics - Crunchbase Company Profile
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.See details»
Caristo.com
Caristo Diagnostic's Management team is led by Frank Cheng, CEO. The Leadership team includes Prof Charalambos Antoniades, Prof Keith ChannonSee details»
Caristo Diagnostics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Caristo Diagnostics. Use the PitchBook Platform to explore the full profile.See details»
Caristo Diagnostics - LinkedIn
Caristo Diagnostics has been formed to bring revolutionary cardiovascular diagnostic tools to patients worldwide. Our proprietary technology transforms the accuracy of routine cardiac CT scans by ...See details»
Caristo Diagnostics - BGF
Caristo was founded in 2018 by cardiologists at the University of Oxford, following a decade of scientific research and technical development, and is now a leader in supporting the …See details»
Caristo Diagnostics - Craft
Caristo Diagnostics $5.11 m in total funding,. See insights on Caristo Diagnostics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Caristo Diagnostics - VentureRadar
"Caristo’s novel technology transforms the diagnostic accuracy of routine coronary CT angiograms, a test used to identify patients with suspected heart disease. Using artificial …See details»
Caristo Diagnostics - Funding, Financials, Valuation & Investors
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.See details»
Caristo Diagnostics - Products, Competitors, Financials, Employees ...
About Caristo Diagnostics Caristo Diagnostics is a global leader in cardiac and vascular disease diagnostics and risk prediction. Founded in 2018 as a spin-out company from the University of …See details»
Caristo Diagnostics Completes Series A Financing and Welcomes …
Apr 17, 2023 Caristo will use the capital to advance its CaRi-Heart® technology, an AI-assisted diagnostics and risk prediction tool, into standards of cardiac care in major global markets.See details»
Caristo Diagnostics - Oxford Innovation Advice
Caristo’s COO Dr Dan Green, commenting on how the IPO funded audit has been beneficial to the business: “We are a high-tech, knowledge-intensive company, so the right strategy to …See details»
Caristo.com
Since 2018, Caristo has collaborated with the world’s leading universities and academic medical centresin research projects on coronary artery diseases and novel biomarkers (such as the …See details»
Caristo.com
Learn about our partners, collaborators, and distinguished cardiologists, offering CaRi-Heart technology in their clinics and hospitals. ReachSee details»
Caristo.com
Mar 19, 2024 Caristo Diagnostics is a global leader in cardiac and vascular disease diagnostics and risk prediction. Founded in 2018 as a spin-out company from the University of Oxford, the …See details»
Caristo Diagnostics Completes Series A Financing and ... - BioSpace
Apr 17, 2023 Caristo Diagnostics Limited today announced it has secured a further £13 million ( US$16.3 million ) to conclude its Series A financing round.See details»
Oxford-based Caristo Diagnostics bags €14.7M for AI-powered …
Oxford-based Caristo Diagnostics, a company that specialises in cardiac and vascular disease diagnostics and risk prediction, announced on Monday, April 18, that it has secured £13M …See details»
Caristo Diagnostics Completes Series A Financing and Welcomes …
Apr 17, 2023 Caristo will use the capital to advance its CaRi-Heart® technology, an AI-assisted diagnostics and risk prediction tool, into standards of cardiac care in major global markets. The …See details»
Caristo Secures FDA Clearance, Ushering in a New Era of AI …
Mar 11, 2025 FDA 510(k) clearance of Caristo's CaRi-Plaque™ technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems...See details»
Caristo.com
Take a look at our patient resources that are created to help you understand your heart disease better. Find out how the CaRi-Heart® analysis is conducted and what to expect from the …See details»